ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 678,41
1,25%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PDS Biotechnology Corporation (PDSB)

  7. PDS Biotechnology Corporation (PDSB) Actualités

PDSB PDS Biotechnology Corporation

3,89
0,16 (4,29%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PDS Biotechnology Corporation PDSB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,16 4,29% 3,89 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,85 3,74 3,96 3,82 3,73
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202423:10EDGAR2Form 8-K - Current report
22/1/202422:45GLOBEPDS Biotech Announces Retirement of Lauren V. Wood, M.D.,..
16/1/202414:00GLOBEPDS Biotech to Participate at B. Riley Securities 4th Annual..
04/12/202322:50GLOBEPDS Biotechnology Reports Inducement Grant Under Nasdaq..
04/12/202322:02EDGAR2Form 8-K - Current report
28/11/202313:30GLOBEPDS Biotech Appoints Lars Boesgaard as Chief Financial..
28/11/202312:02EDGAR2Form 8-K - Current report
14/11/202313:30GLOBEPDS Biotech Reports Third Quarter 2023 Financial Results and..
09/11/202322:07EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEPDS Biotech Announces Updated Survival Data from NCI-Led..
07/11/202314:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
23/10/202322:06EDGAR2Form 8-K - Current report
23/10/202314:00GLOBEPDS Biotech Announces Preliminary Biomarker Study Results in..
11/10/202322:02EDGAR2Form 8-K - Current report
11/10/202314:00GLOBEPDS Biotech Announces Interim Safety and Immune Response..
03/10/202322:03EDGAR2Form 8-K - Current report
03/10/202322:03EDGAR2Form 8-K - Current report
03/10/202315:02EDGAR2Form 8-K - Current report
03/10/202313:00GLOBEPDS Biotech Announces Interim 24-Month Survival Rate of 74%..
02/10/202322:05EDGAR2Form 8-K - Current report
02/10/202314:00GLOBEPDS Biotech Announces PDS0101 Combined with..
26/9/202314:00GLOBEPDS Biotech to Present at the LD Micro Main Event XVI
25/9/202314:00GLOBEPDS Biotech Reschedules Key Opinion Leader Roundtable..
20/9/202322:10EDGAR2Form 8-K - Current report
20/9/202322:05GLOBEPDS Biotech to Participate in the 2023 Cantor Fitzgerald..
20/9/202314:00GLOBEPDS Biotech Announces PDS0202 Elicits Active Neutralization..
13/9/202314:00GLOBEPDS Biotech to Host Key Opinion Leader Roundtable Addressing..
11/9/202322:05EDGAR2Form 8-K - Current report
08/9/202312:02EDGAR2Form 8-K - Current report
06/9/202322:05GLOBEPDS Biotech to Participate at the H.C. Wainwright 25th..
06/9/202314:00GLOBEPDS0202 Universal Influenza Preclinical Ferret Data to be..
18/8/202322:04EDGAR2Form 8-K - Current report
17/8/202322:05EDGAR2Form 8-K - Current report
16/8/202314:00GLOBEPDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial..
14/8/202322:05EDGAR2Form 8-K - Current report
14/8/202319:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:30GLOBEPDS Biotech Reports Second Quarter 2023 Financial Results..
14/8/202313:00GLOBEPDS Biotech Announces Submission of Phase 3 Protocol to FDA..
07/8/202314:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
02/8/202314:00GLOBEPDS Biotech to Present at BTIG Virtual Biotechnology..
25/7/202322:01EDGAR2Form 8-K - Current report
25/7/202314:00GLOBEPDS Biotech to Present Immune Response Data from Combination..
17/7/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202323:24EDGAR2Form 8-K - Current report
17/7/202323:23EDGAR2Form 8-K - Current report
17/7/202314:00GLOBEPDS Biotech Announces Acceptance of Abstract on Combination..

Dernières Valeurs Consultées

NASDAQ
PDSB
PDS Biotechnology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés